Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study (npj Parkinson's Disease, (2023), 9, 1, (156), 10.1038/s41531-023-00595-w)

on behalf of the NCER-PD Consortium, Sinthuja Pachchek, Zied Landoulsi, Lukas Pavelka, Claudia Schulte, Elena Buena-Atienza, Caspar Gross, Ann Kathrin Hauser, Dheeraj Reddy Bobbili, Nicolas Casadei, Patrick May, Rejko Krüger, Geeta Acharya, Gloria Aguayo, Myriam Alexandre, Muhammad Ali, Wim Ammerlann, Giuseppe Arena, Rudi Balling, Michele BassisRoxane Batutu, Katy Beaumont, Regina Becker, Camille Bellora, Guy Berchem, Daniela Berg, Alexandre Bisdorff, Ibrahim Boussaad, David Bouvier, Kathrin Brockmann, Jessica Calmes, Lorieza Castillo, Gessica Contesotto, Nancy De Bremaeker, Nico Diederich, Rene Dondelinger, Nancy E. Ramia, Daniela Esteves, Guy Fagherazzi, Jean Yves Ferrand, Katrin Frauenknecht, Manon Gantenbein, Thomas Gasser, Piotr Gawron, Soumyabrata Ghosh, Marijus Giraitis, Enrico Glaab, Martine Goergen, Elisa Gómez De Lope, Jérôme Graas, Mariella Graziano, Valentin Groues, Anne Grünewald, Wei Gu, Gaël Hammot, Anne Marie Hanff, Linda Hansen, Michael Heneka, Estelle Henry, Sylvia Herbrink, Sascha Herzinger, Michael Heymann, Michele Hu, Alexander Hundt, Nadine Jacoby, Jacek Jaroslaw Lebioda, Yohan Jarosz, Sonja Jónsdóttir, Quentin Klopfenstein, Jochen Klucken, Rejko Krüger, Pauline Lambert, Roseline Lentz, Inga Liepelt, Robert Liszka, Laura Longhino, Victoria Lorentz, Paula Cristina Lupu, Tainá M. Marques, Clare Mackay, Walter Maetzler, Katrin Marcus, Guilherme Marques, Patricia Martins Conde, Deborah Mcintyre, Chouaib Mediouni, Francoise Meisch, Myriam Menster, Maura Minelli, Michel Mittelbronn, Brit Mollenhauer, Friedrich Mühlschlegel, Romain Nati, Ulf Nehrbass, Sarah Nickels, Beatrice Nicolai, Jean Paul Nicolay, Fozia Noor, Marek Ostaszewski, Clarissa P. C. Gomes, Claire Pauly, Laure Pauly, Lukas Pavelka, Magali Perquin, Rosalina Ramos Lima, Armin Rauschenberger, Rajesh Rawal, Kirsten Roomp, Eduardo Rosales, Isabel Rosety, Estelle Sandt, Stefano Sapienza, Venkata Satagopam, Margaux Schmitt, Sabine Schmitz, Reinhard Schneider, Jens Schwamborn, Raquel Severino, Amir Sharify, Ekaterina Soboleva, Kate Sokolowska, Hermann Thien, Elodie Thiry, Rebecca Ting Jiin Loo, Christophe Trefois, Johanna Trouet, Olena Tsurkalenko, Michel Vaillant, Mesele Valenti, Gilles Van Cutsem, Carlos Vega, Liliana Vilas Boas, Maharshi Vyas, Richard Wade-Martins, Paul Wilmes, Evi Wollscheid-Lengeling, Gelani Zelimkhanov

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

npj Parkinson’s Disease, published online 23 November 2023 In this article the wrong Table appeared as Table 3.; the Table should have appeared as shown below. The original article has been corrected. The following text that describes data from the previous version of Table 3 has also been removed: “Compared to severe (6.4 ± 4.7) and risk (4.4 ± 4.9) variant carriers, the mild (1.7 ± 1.4) variant carriers show a significantly shorter disease duration (Table 3).” (Table presented.) Features All pathogenic variants (n = 67) Severe (n = 21) Mild (n = 7) Risk (n = 39) Non carriers (n = 554) AAA, mean (SD) 66.5 (±10.2) [OR = 0.31; p = 0.3977] 65.1 (±10.2) [OR = 0.08; p = 0.292] 67.1 (±15.6) [OR = 0.59; p = 0.8959] 67.1 (±9.2) [OR = 0.57; p = 0.7512] 67.6 (±10.7) Sex, Male n (%) 40 (59.7%) [OR = 0.71; p = 0.1912] 13 (61.9%) [OR = 0.78; p = 0.5795] 5 (71.4%) [OR = 1.19; p = 0.8336] 22 (56.4%) [OR = 0.62; p = 0.151] 375 (67.7%) AAO, mean (SD) 61.6 (±11.5) [OR = 0.35; p = 0.484] 58.6 (±13.1) [OR = 0.02; p = 0.1158] 65.4 (±17.0) [OR = 16.16; p = 0.5308] 62.5 (±9.3) [OR = 0.9; p = 0.9548] 62.6 (±11.6) AAO < 45, N (%) 8 (11.9%) [OR = 1.74; p = 0.1767] 2 (28.6%) [OR = 5.14; p = 0.0549] 1 (2.6%) [OR = 0.34; p = 0.2907] 40 (7.2%) Disease Duration, mean (SD) 4.7 (±4.8) [OR = 0.79; p = 0.7303] 6.4 (±4.7) [OR = 4.07; p = 0.2238] 1.7 (±1.4) [OR = 0.04; p =0.0981] 4.4 (±4.9) [OR = 0.57; p = 0.5103] 5.0 (±5.2) Family History, N (%) 8 (38.1%) [OR = 1.8; p = 0.2001] 2 (28.6% [OR = 1.17; p = 0.8508] 15 (38.5%) [OR = 1.83; p = 0.0782] 141 (25.5%).

Original languageEnglish
Article number168
Journalnpj Parkinson's Disease
Volume9
Issue number1
DOIs
StatePublished - Dec 2023

Fingerprint

Dive into the research topics of 'Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study (npj Parkinson's Disease, (2023), 9, 1, (156), 10.1038/s41531-023-00595-w)'. Together they form a unique fingerprint.

Cite this